108 related articles for article (PubMed ID: 26523991)
1. In vivo evidence for chylomicrons as mediators of postprandial inflammation.
de Vries MA; Klop B; Alipour A; van de Geijn GJ; Prinzen L; Liem AH; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; Castro Cabezas M
Atherosclerosis; 2015 Dec; 243(2):540-5. PubMed ID: 26523991
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte activation by triglyceride-rich lipoproteins.
Alipour A; van Oostrom AJ; Izraeljan A; Verseyden C; Collins JM; Frayn KN; Plokker TW; Elte JW; Castro Cabezas M
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):792-7. PubMed ID: 18218988
[TBL] [Abstract][Full Text] [Related]
3. Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk.
Irawati D; Mamo JC; Slivkoff-Clark KM; Soares MJ; James AP
Br J Nutr; 2017 Feb; 117(3):403-412. PubMed ID: 28215212
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis.
van Oostrom AJ; Plokker HW; van Asbeck BS; Rabelink TJ; van Kessel KP; Jansen EH; Stehouwer CD; Cabezas MC
Atherosclerosis; 2006 Apr; 185(2):331-9. PubMed ID: 16098531
[TBL] [Abstract][Full Text] [Related]
5. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
Smith D; Watts GF; Dane-Stewart C; Mamo JC
Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
[TBL] [Abstract][Full Text] [Related]
6. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
[TBL] [Abstract][Full Text] [Related]
7. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
8. Prior exercise does not affect chylomicron particle number following a mixed meal of moderate fat content.
James AP; Slivkoff-Clark K; Mamo JC
Lipids Health Dis; 2007 Mar; 6():8. PubMed ID: 17394665
[TBL] [Abstract][Full Text] [Related]
9. Evidence for increased chylomicron remnants in rheumatoid arthritis.
Burggraaf B; van Breukelen-van der Stoep DF; van Zeben J; van der Meulen N; van de Geijn GM; Liem A; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; van der Zwan E; Castro Cabezas M
Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29231984
[TBL] [Abstract][Full Text] [Related]
10. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
Masuda D; Sugimoto T; Tsujii K; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Kawamoto T; Matsuyama A; Sakai N; Komuro I; Yamashita S
Eur J Clin Invest; 2012 Sep; 42(9):992-9. PubMed ID: 22587365
[TBL] [Abstract][Full Text] [Related]
11. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
[TBL] [Abstract][Full Text] [Related]
12. Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome.
Kinoshita M; Ohnishi H; Maeda T; Yoshimura N; Takeoka Y; Yasuda D; Kusano J; Mashimo Y; Saito S; Shimamoto K; Teramoto T
J Atheroscler Thromb; 2009 Aug; 16(4):517-22. PubMed ID: 19713673
[TBL] [Abstract][Full Text] [Related]
13. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte cell population data (volume conductivity scatter) in postprandial leukocyte activation.
Klop B; van de Geijn GJ; Njo TL; Janssen HW; Rietveld AP; van Miltenburg A; Fernández-Sender L; Elte JW; Castro Cabezas M
Int J Lab Hematol; 2013 Dec; 35(6):644-51. PubMed ID: 23663689
[TBL] [Abstract][Full Text] [Related]
15. Effects of magnesium on postprandial serum lipid responses in healthy human subjects.
Kishimoto Y; Tani M; Uto-Kondo H; Saita E; Iizuka M; Sone H; Yokota K; Kondo K
Br J Nutr; 2010 Feb; 103(4):469-72. PubMed ID: 19941679
[TBL] [Abstract][Full Text] [Related]
16. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
17. Activation of leukocytes by postprandial lipemia in healthy volunteers.
van Oostrom AJ; Rabelink TJ; Verseyden C; Sijmonsma TP; Plokker HW; De Jaegere PP; Cabezas MC
Atherosclerosis; 2004 Nov; 177(1):175-82. PubMed ID: 15488881
[TBL] [Abstract][Full Text] [Related]
18. A low-protein diet exacerbates postprandial chylomicron concentration in moderately dyslipidaemic subjects in comparison to a lean red meat protein-enriched diet.
Mamo JC; James AP; Soares MJ; Griffiths DG; Purcell K; Schwenke JL
Eur J Clin Nutr; 2005 Oct; 59(10):1142-8. PubMed ID: 16015257
[TBL] [Abstract][Full Text] [Related]
19. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study).
Tiret L; Gerdes C; Murphy MJ; Dallongeville J; Nicaud V; O'Reilly DS; Beisiegel U; De Backer G
Eur J Clin Invest; 2000 Jul; 30(7):578-85. PubMed ID: 10886297
[TBL] [Abstract][Full Text] [Related]
20. Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.
Valdivielso P; Puerta S; Rioja J; Alonso I; Ariza MJ; Sánchez-Chaparro MA; Palacios R; González-Santos P
Clin Chim Acta; 2010 Mar; 411(5-6):433-7. PubMed ID: 20059992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
